Search Results - "STEINBRÜCHEL, Daniel A"

No Major Differences in 30-Day Outcomes in High-Risk Patients Randomized to Off-Pump Versus On-Pump Coronary Bypass Surgery: The Best Bypass Surgery Trial by MØLLER, Christian H, PERKO, Mario J, LUND, Jens T, ANDERSEN, Lars W, KELBAEK, Henning, MADSEN, Jan K, WINKEL, Per, GLUUD, Christian, STEINBRIICHEL, Daniel A

“…Off-pump coronary artery bypass grafting compared with coronary revascularization with cardiopulmonary bypass seems safe and results in about the same outcome…”
Get full text

Acute Kidney Injury Is Independently Associated With Higher Mortality After Cardiac Surgery by Kandler, Kristian, MD, Jensen, Mathias E., MS, Nilsson, Jens C., MD, PhD, Møller, Christian H., MD, PhD, Steinbrüchel, Daniel A., MD, DMSc

“…Objectives To investigate the incidence of acute kidney injury after cardiac surgery and its association with mortality in a patient population receiving…”
Get full text

Evaluation of the TEG platelet mapping assay in blood donors by Bochsen, Louise, Wiinberg, Bo, Kjelgaard-Hansen, Mads, Steinbrüchel, Daniel A, Johansson, Pär I

“…Monitoring of antiplatelet therapy in patients at cardiovascular risk is difficult because existing platelet function tests are too sophisticated for clinical…”
Get full text

Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial by Buggeskov, Katrine B, Sundskard, Martin M, Jonassen, Thomas, Andersen, Lars W, Secher, Niels H, Ravn, Hanne B, Steinbrüchel, Daniel A, Jakobsen, Janus C, Wetterslev, Jørn

“…IntroductionAbsence of pulmonary perfusion during cardiopulmonary bypass (CPB) may be associated with reduced postoperative oxygenation. Effects of active…”
Get full text

Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease by Møller, Christian H, Penninga, Luit, Wetterslev, Jørn, Steinbrüchel, Daniel A, Gluud, Christian

“…Coronary artery bypass grafting (CABG) is performed both without and with cardiopulmonary bypass, referred to as off-pump and on-pump CABG respectively…”
Get more information

Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release by Komarowska, Izabela, Coe, David, Wang, Guosu, Haas, Robert, Mauro, Claudio, Kishore, Madhav, Cooper, Dianne, Nadkarni, Suchita, Fu, Hongmei, Steinbruchel, Daniel A., Pitzalis, Costantino, Anderson, Graham, Bucy, Pat, Lombardi, Giovanna, Breckenridge, Ross, Marelli-Berg, Federica M.

“…Effector-T-cell-mediated immunity depends on the efficient localization of antigen-primed lymphocytes to antigen-rich non-lymphoid tissue, which is facilitated…”
Get full text

Comparable three months' outcome of total arterial revascularization versus conventional coronary surgery: Copenhagen Arterial Revascularization Randomized Patency and Outcome trial by Damgaard, Sune, MD, Lund, Jens T., MD, Lilleør, Nikolaj B., RN, Perko, Mario J., MD, DMSc, Sander, Kåre, MD, DMSc, Dimo, Blagoja, MD, Jensen, Maiken B., MD, Madsen, Jan K., MD, DMSc, Kelbæk, Henning, MD, DMSc, Steinbrüchel, Daniel A., MD, DMSc

“…Objective The in-hospital safety of total arterial revascularization for coronary artery bypass surgery seems to be comparable to conventional…”
Get full text

Transit-Time Flow Measurement as a Predictor of Coronary Bypass Graft Failure at One Year Angiographic Follow-Up by Lehnert, Per, Møller, Christian H., Damgaard, Sune, Gerds, Thomas A., Steinbrüchel, Daniel A.

“…Background Transit‐time flow measurement (TTFM) is a commonly used intraoperative method for evaluation of coronary artery bypass graft (CABG) anastomoses…”
Get full text

Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients by Penninga, Luit, Penninga, Elisabeth I, Møller, Christian H, Iversen, Martin, Steinbrüchel, Daniel A, Gluud, Christian

“…Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary…”
Get more information

Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials by Penninga, Luit, Møller, Christian H, Gustafsson, Finn, Steinbrüchel, Daniel A, Gluud, Christian

“…Purpose We conducted a systematic review of randomized trials to compare the benefits and harms of tacrolimus versus cyclosporine as primary immunosuppression…”
Get full text

Clinical outcomes in randomized trials of off- vs. on-pump coronary artery bypass surgery: systematic review with meta-analyses and trial sequential analyses by Møller, Christian H., Penninga, Luit, Wetterslev, Jørn, Steinbrüchel, Daniel A., Gluud, Christian

“…Aims To assess the clinical outcomes of off- vs. on-pump coronary artery bypass surgery in randomized trials. Methods and results We searched electronic…”
Get full text

Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial by Rafiq, Sulman, Johansson, Pär I., Kofoed, Klaus F., Lund, Jens T., Olsen, Peter S., Bentsen, Simon, Steinbrüchel, Daniel A.

“…A hypercoagulable state has, in observational studies, been associated with increased risk of thromboembolic events. The aim of this trial was to study whether…”
Get full text

Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting : A randomized trial by JENSEN, Birte Ostergaard, HUGHES, Pia, RASMUSSEN, Lars S, PEDERSEN, Preben U, STEINBRÜCHEL, Daniel A

“…It has been suggested that the risk of cerebral dysfunction is less with off-pump coronary artery bypass grafting (OPCAB) than with conventional coronary…”
Get full text

Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients by Penninga, Luit, Wettergren, André, Wilson, Colin H, Chan, An-Wen, Steinbrüchel, Daniel A, Gluud, Christian

“…Liver transplantation is an established treatment option for end-stage liver failure. To date, no consensus has been reached on the use of immunosuppressive…”
Get more information

Higher arterial pressure during cardiopulmonary bypass may not reduce the risk of acute kidney injury by Kandler, Kristian, Nilsson, Jens C, Oturai, Peter, Jensen, Mathias E, Møller, Christian H, Clemmesen, Jens Otto, Arendrup, Henrik C, Steinbrüchel, Daniel A

“…Acute kidney injury after cardiac surgery is common and associated with increased mortality. It is unknown whether an intended higher arterial pressure during…”
Get full text

Immunosuppressive T-cell antibody induction for heart transplant recipients by Penninga, Luit, Møller, Christian H, Gustafsson, Finn, Gluud, Christian, Steinbrüchel, Daniel A

“…Heart transplantation has become a valuable and well-accepted treatment option for end-stage heart failure. Rejection of the transplanted heart by the…”
Get more information

Cognitive outcomes in elderly high-risk patients 1 year after off-pump versus on-pump coronary artery bypass grafting. A randomized trial by Jensen, Birte Østergaard, Rasmussen, Lars S., Steinbrüchel, Daniel A.

“…Objective: Age is considered to be the strongest predictive factor of postoperative cognitive dysfunction (POCD) after cardiac surgery. Coronary artery bypass…”
Get full text

Three-year follow-up in a subset of high-risk patients randomly assigned to off-pump versus on-pump coronary artery bypass surgery: the Best Bypass Surgery trial by Møller, Christian H, Perko, Mario J, Lund, Jens T, Andersen, Lars W, Kelbæk, Henning, Madsen, Jan K, Winkel, Per, Gluud, Christian, Steinbrüchel, Daniel A

“…To evaluate off-pump versus on-pump coronary artery bypass grafting (CABG) in patients with three-vessel disease and a high-risk operative profile. A…”
Get more information

Antibody induction therapy for lung transplant recipients by Penninga, Luit, Møller, Christian H, Penninga, Elisabeth I, Iversen, Martin, Gluud, Christian, Steinbrüchel, Daniel A

“…Lung transplantation has become a valuable and well-accepted treatment option for most end-stage lung diseases. Lung transplant recipients are at risk of…”
Get more information

Antibody induction versus corticosteroid induction for liver transplant recipients by Penninga, Luit, Wettergren, André, Wilson, Colin H, Chan, An-Wen, Steinbrüchel, Daniel A, Gluud, Christian

“…Liver transplantation is an established treatment option for end-stage liver failure. To date, no consensus has been reached on the use of immunosuppressive…”
Get more information